• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【药物名称】Aliskiren fumarate, CGP-60536(free base), SPP-100B, SPP-100(free base), CGP-60536B, Rasilez

【化学名称】(2S,4S,5S,7S)-5-Amino-N-(2-carbamoyl-2-methylpropyl)-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methylnonanamide hemifumarate

【CA登记号】173334-58-2, 173334-57-1 (free base), 173399-03-6 (monohydrochloride)

【 分 子 式 】C64H110N6O16

【 分 子 量 】1219.6209

【开发单位】Novartis (Originator), Speedel (Licensee)

【药理作用】CARDIOVASCULAR DRUGS, Heart Failure Therapy, Hypertension, Treatment of, Renal Failure, Agents for, RENAL-UROLOGIC DRUGS, Treatment of Renal Diseases, Renin Inhibitors

合成路线1

Alkylation of 3-hydroxy-4-methoxybenzyl alcohol (I) with 1-bromo-3-methoxypropane (II) gives ether (III). Subsequent conversion of benzyl alcohol (III) into bromide (IV) is carried out using bromotrimetylsilane. The chiral isovaleryloxazolidinone (V) is alkylated with bromide (IV) by means of LiHMDS to afford (VI), which is hydrolyzed to the (S)-2-aryl-2-isopropylpropionic acid (VII) by means of lithium peroxide. The reduction of acid (VII) to the corresponding alcohol with NaBH4/I2 reagent, followed by treatment with PPh3 and NBS, provides bromide (VIII). Alkylation of the chiral dimethoxydihydropyrazin (IX) with bromide (VIII) produces (X). Further hydrolysis of the pyrazine ring of (X) with HCl, followed by Boc protection of the resulting (S,S)-amino ester, yields compound (XI). Reduction of the ester group of (XI) with DIBAL gives aldehyde (XII). This compound is condensed with the Grignard reagent (XIII) to afford the diastereomeric mixture of amino alcohols (XIV). Treatment of mixture (XIV) with 2,2-dimethoxypropane (XV) and TsOH produces a mixture of oxazolidines, from which the required (S,S,S)-isomer (XVI) is isolated by flash chromatography. Hydrogenolitic deprotection of the benzyl ether of (XVI) gives alcohol (XVII).

1 Mealy, N.E.; Castañer, R.M.; Silvestre, J.S.; Castañer, J.; Aliskiren Fumarate. Drugs Fut 2001, 26, 12, 1139.
2 Rigollier, P.; Stutz, S.; Goeschke, R.; Yamaguchi, Y.; Maibaum, J.; Wood, J.; Structural modification of the P2' position of 2,7-dialkyl substituted 5(S)-amino-4(S)-hydroxy-8-phenyl-octane-carboxamides: Discovery of a potent non-peptide renin inhibitor active after once daily dosing in marmosets. 15th European Federation for Medicinal Chemistry International Symposium on Medicinal Chemistry (Sept 6 1998, Edinburgh) 1998, Abst P.230.
3 Göschke, R.; Maibaum, J.K.; Schilling, W.; Stutz, S.; Rigollier, P.; Yamaguchi, Y.; Cohen, N.C.; Herold, P. (Novartis AG); Delta-amino-gamma-hydroxy-omega-aryl alkanoic acid amides with enzyme especially renin inhibiting activities. EP 0678500; EP 0678503; JP 1996053434; JP 1996081430; US 5559111; US 5627182; US 5646143 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 28115 5-(hydroxymethyl)-2-methoxyphenol 4383-06-6 C8H10O3 详情 详情
(II) 17319 1-bromo-3-methoxypropane; 3-bromopropyl methyl ether C4H9BrO 详情 详情
(III) 28116 [4-methoxy-3-(3-methoxypropoxy)phenyl]methanol 172900-74-2 C12H18O4 详情 详情
(IV) 28117 3-[5-(bromomethyl)-2-methoxyphenoxy]propyl methyl ether 172900-73-1 C12H17BrO3 详情 详情
(V) 28131 (4S)-4-benzyl-3-(3-methylbutanoyl)-1,3-oxazolidin-2-one C15H19NO3 详情 详情
(VI) 28118 (4S)-4-benzyl-3-[(2R)-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methylbutanoyl]-1,3-oxazolidin-2-one C27H35NO6 详情 详情
(VII) 28119 (2R)-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methylbutyric acid C17H26O5 详情 详情
(VIII) 28120 3-[5-[(2R)-2-(bromomethyl)-3-methylbutyl]-2-methoxyphenoxy]propyl methyl ether 172900-69-5 C17H27BrO3 详情 详情
(IX) 10296 (R)-2,5-Dihydro-3,6-dimethoxy-2-isopropylpyrazine; (3R)-3-Isopropyl-5-methoxy-3,6-dihydro-2-pyrazinyl methyl ether; (2R)-2-Isopropyl-3,6-dimethoxy-2,5-dihydropyrazine 109838-85-9 C9H16N2O2 详情 详情
(X) 28121 (2R,5S)-2-isopropyl-3,6-dimethoxy-5-[(2S)-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methylbutyl]-2,5-dihydropyrazine C26H42N2O5 详情 详情
(XI) 28122 methyl (2S,4S)-2-[(tert-butoxycarbonyl)amino]-4-[4-methoxy-3-(3-methoxypropoxy)benzyl]-5-methylhexanoate C25H41NO7 详情 详情
(XII) 28123 tert-butyl (1S,3S)-1-formyl-3-[4-methoxy-3-(3-methoxypropoxy)benzyl]-4-methylpentylcarbamate C24H39NO6 详情 详情
(XIII) 28124 [(2S)-2-[(benzyloxy)methyl]-3-methylbutyl](bromo)magnesium C13H19BrMgO 详情 详情
(XIV) 28125 tert-butyl (1S,4S)-4-[(benzyloxy)methyl]-2-hydroxy-1-[(2S)-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methylbutyl]-5-methylhexylcarbamate C37H59NO7 详情 详情
(XV) 10722 1-Methoxy-1-methylethyl methyl ether; 2,2-Dimethoxypropane 77-76-9 C5H12O2 详情 详情
(XVI) 28126 tert-butyl (4S,5S)-5-[(2S)-2-[(benzyloxy)methyl]-3-methylbutyl]-4-[(2S)-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methylbutyl]-2,2-dimethyl-1,3-oxazolidine-3-carboxylate C40H63NO7 详情 详情
(XVII) 28127 tert-butyl (4S,5S)-5-[(2S)-2-(hydroxymethyl)-3-methylbutyl]-4-[(2S)-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methylbutyl]-2,2-dimethyl-1,3-oxazolidine-3-carboxylate C33H57NO7 详情 详情

合成路线2

This alcohol is oxidized to aldehyde with NMMO and tetrapropylammonium perruthenate (TPAP), and further oxidized to carboxylic acid (XVIII) with KMnO4 and tetrabutylammonium bromide (TBAB). Coupling of (XVIII) with aminoamide (XIX) by means of diethyl cyanophosphonate and TEA gives (XX). Finally, acid hydrolysis of the oxazolidine ring and Boc protecting groups of (XX) furnishes the corresponding amino alcohol, which is finally converted to the hemifumarate salt.

1 Mealy, N.E.; Castañer, R.M.; Silvestre, J.S.; Castañer, J.; Aliskiren Fumarate. Drugs Fut 2001, 26, 12, 1139.
2 Rigollier, P.; Stutz, S.; Goeschke, R.; Yamaguchi, Y.; Maibaum, J.; Wood, J.; Structural modification of the P2' position of 2,7-dialkyl substituted 5(S)-amino-4(S)-hydroxy-8-phenyl-octane-carboxamides: Discovery of a potent non-peptide renin inhibitor active after once daily dosing in marmosets. 15th European Federation for Medicinal Chemistry International Symposium on Medicinal Chemistry (Sept 6 1998, Edinburgh) 1998, Abst P.230.
3 Göschke, R.; Maibaum, J.K.; Schilling, W.; Stutz, S.; Rigollier, P.; Yamaguchi, Y.; Cohen, N.C.; Herold, P. (Novartis AG); Delta-amino-gamma-hydroxy-omega-aryl alkanoic acid amides with enzyme especially renin inhibiting activities. EP 0678500; EP 0678503; JP 1996053434; JP 1996081430; US 5559111; US 5627182; US 5646143 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
42235 Diethyl phosphorocyanidate; Diethyl cyanophosphonate; Cyanophosphonic acid diethyl ester; Diethyl phosphoryl cyanide; DEPC 2942-58-7 C5H10NO3P 详情 详情
(XVIII) 28128 (2S)-2-[((4S,5S)-3-(tert-butoxycarbonyl)-4-[(2S)-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methylbutyl]-2,2-dimethyl-1,3-oxazolidin-5-yl)methyl]-3-methylbutyric acid C33H55NO8 详情 详情
(XIX) 28129 3-amino-2,2-dimethylpropanamide 324763-51-1 C5H12N2O 详情 详情
(XX) 28130 tert-butyl (4S,5S)-5-((2S)-2-[[(3-amino-2,2-dimethyl-3-oxopropyl)amino]carbonyl]-3-methylbutyl)-4-[(2S)-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methylbutyl]-2,2-dimethyl-1,3-oxazolidine-3-carboxylate C38H65N3O8 详情 详情

合成路线3

The intermediate gamma-butyrolactone (XXVIII) has been obtained as follows: Allylation of the imidazolidinone intermediate (V) with allyl bromide (XXI) and LiHMDS in THF gives the chiral intermediate (XXII), which by dihydroxylation and cleavage of the chiral auxiliary with OsO4 and NMMO in tert-butanol/acetone/water yields the lactone alcohol (XXIII). Oxidation of (XXIII) with NaIO4 and RuCl3 in CCl4/acetonitrile/water affords the carboxylic acid (XXIV), which by treatment with (COCl)2 in toluene provides the acyl chloride (XXV). Esterification of (XXV) with benzyl alcohol gives the corresponding benzyl ester as a diastereomeric mixture, from which the desired isomer (XXVI) is separated by flash chromatography. Hydrogenolysis of the benzyl ester (XXVI) with H2 over Pd/C in ethyl acetate yields the carboxylic acid (XXVII), which is treated with oxalyl chloride in toluene to afford the desired gamma-butyrolactone intermediate (XXVIII).

1 Mealy, N.E.; Castañer, R.M.; Silvestre, J.S.; Castañer, J.; Aliskiren Fumarate. Drugs Fut 2001, 26, 12, 1139.
2 Rüeger, H.; Maibaum, J.; Stutz, S.; Spindler, F.; Göschke, R.; A convergent synthesis approach towards CGP60536B, a non-peptide orally potent renin inhibitor, via an enantiomerically pure ketolactone intermediate. Tetrahedron Lett 2000, 41, 51, 10085.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(V) 28131 (4S)-4-benzyl-3-(3-methylbutanoyl)-1,3-oxazolidin-2-one C15H19NO3 详情 详情
(XXI) 11463 3-Bromo-1-propene; 3-Bromopropene;allyl bromide 106-95-6 C3H5Br 详情 详情
(XXII) 50566 (4S)-4-benzyl-3-[(2S)-2-isopropyl-4-pentenoyl]-1,3-oxazolidin-2-one C18H23NO3 详情 详情
(XXIII) 50567 (3S)-5-(hydroxymethyl)-3-isopropyldihydro-2(3H)-furanone C8H14O3 详情 详情
(XXIV) 50568 (4S)-4-isopropyl-5-oxotetrahydro-2-furancarboxylic acid C8H12O4 详情 详情
(XXV) 50569 (4S)-4-isopropyl-5-oxotetrahydro-2-furancarbonyl chloride C8H11ClO3 详情 详情
(XXVI) 50570 benzyl (2S,4S)-4-isopropyl-5-oxotetrahydro-2-furancarboxylate C15H18O4 详情 详情
(XXVII) 50571 (2S,4S)-4-isopropyl-5-oxotetrahydro-2-furancarboxylic acid C8H12O4 详情 详情
(XXVIII) 50572 (2S,4S)-4-isopropyl-5-oxotetrahydro-2-furancarbonyl chloride C8H11ClO3 详情 详情

合成路线4

The reduction of the chiral propionic acid (VII) with NaBH4 in THF gives the primary alcohol (XXIX), which by reaction with SOCl2 and pyridine in CHCl3 yields the chloride (XXX). Condensation of (XXX) with the butyrolactone intermediate (XXVII) by means of Mg and dibromoethane affords the ketonic adduct (XXXI). Reduction of the exocyclic carbonyl group of (XXXI) with NaBH4 in THF/ methanol provides a 3:1 diastereomeric mixture of the desired chiral alcohol (XXXII) and its OH-epimer (XXXIII) that are separated by flash chromatography. Reaction of (XXXII) with MsCl and TEA, followed by treatment with NaN3, affords the azido derivative (XXXIV), which is condensed with 4-amino-3,3-dimethylbutyramide (XIX) by means of 2-hydroxypyridine and TEA to provide the adduct (XXXV). Finally, the azido group of (XXXV) is reduced with H2 over Pd/ in MeOH to yield the target amino alcohol. An extensive study on the stereoselective reduction of the ketonic adduct (XXXI) has been performed. No better diastereoselectivity than 3:1 has been obtained for the synthesis of the chiral alcohol (XXXII). However, excellent diastereoselectivity (97:3) has been obtained for the synthesis of its OH-epimer, alcohol (XXXIII), with K-selectride in THF, which could potentially provide access to the target amino alcohol via a double inversion protocol.

1 Mealy, N.E.; Castañer, R.M.; Silvestre, J.S.; Castañer, J.; Aliskiren Fumarate. Drugs Fut 2001, 26, 12, 1139.
2 Rüeger, H.; Maibaum, J.; Stutz, S.; Spindler, F.; Göschke, R.; A convergent synthesis approach towards CGP60536B, a non-peptide orally potent renin inhibitor, via an enantiomerically pure ketolactone intermediate. Tetrahedron Lett 2000, 41, 51, 10085.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VII) 28119 (2R)-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methylbutyric acid C17H26O5 详情 详情
(XIX) 28129 3-amino-2,2-dimethylpropanamide 324763-51-1 C5H12N2O 详情 详情
(XXVIII) 50572 (2S,4S)-4-isopropyl-5-oxotetrahydro-2-furancarbonyl chloride C8H11ClO3 详情 详情
(XXIX) 50573 (2R)-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methyl-1-butanol C17H28O4 详情 详情
(XXX) 50574 4-[(2R)-2-(chloromethyl)-3-methylbutyl]-1-methoxy-2-(3-methoxypropoxy)benzene; 3-[5-[(2R)-2-(chloromethyl)-3-methylbutyl]-2-methoxyphenoxy]propyl methyl ether 324763-39-5 C17H27ClO3 详情 详情
(XXXI) 50575 (3S,5S)-3-isopropyl-5-[(3S)-3-[4-methoxy-3-(3-methoxypropoxy)benzyl]-4-methylpentanoyl]dihydro-2(3H)-furanone C25H38O6 详情 详情
(XXXII) 50576 (3S,5S)-5-[(1R,3S)-1-hydroxy-3-[4-methoxy-3-(3-methoxypropoxy)benzyl]-4-methylpentyl]-3-isopropyldihydro-2(3H)-furanone C25H40O6 详情 详情
(XXXIII) 50577 (3S,5S)-5-[(1S,3S)-1-hydroxy-3-[4-methoxy-3-(3-methoxypropoxy)benzyl]-4-methylpentyl]-3-isopropyldihydro-2(3H)-furanone C25H40O6 详情 详情
(XXXIV) 50578 (3S,5S)-5-[(1S,3S)-1-azido-3-[4-methoxy-3-(3-methoxypropoxy)benzyl]-4-methylpentyl]-3-isopropyldihydro-2(3H)-furanone C25H39N3O5 详情 详情
(XXXV) 50579 (2S,4S,5S,7S)-N-(4-amino-2,2-dimethyl-4-oxobutyl)-5-azido-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methylnonanamide C31H53N5O6 详情 详情

合成路线5

Alternatively, the chiral phenylpropyl chloride (XXX) can also be prepared as follows: Reduction of the cinnamic acid (XXXVI) with H2 over Pd/C in ethyl acetate gives the phenylpropionic acid (XXXVII), which is treated with oxalyl chloride to yield the acyl chloride (XXXVIII). Condensation of (XXXVIII) with (+)-pseudoephedrine (XXXIX) by means of NaOH in toluene/water affords the chiral amide (XL), which is enantioselectively alkylated with 2-iodopropane (XLI) by means of LDA in THF to provide the adduct (XLII). Reduction of the amide group of (XLII) with BH3/NH3 in THF gives the already reported primary alcohol (XXIX), which is finally treated with POCl3 in hot toluene to afford the phenylpropyl chloride intermediate (XXX).

1 Mealy, N.E.; Castañer, R.M.; Silvestre, J.S.; Castañer, J.; Aliskiren Fumarate. Drugs Fut 2001, 26, 12, 1139.
2 Carey, J.S.; Sandham, D.A.; Taylor, R.J.; Fassler, A.; A convergent synthesis of the renin inhibitor CGP60536B. Tetrahedron Lett 2000, 41, 51, 10091.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XXIX) 50573 (2R)-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methyl-1-butanol C17H28O4 详情 详情
(XXX) 50574 4-[(2R)-2-(chloromethyl)-3-methylbutyl]-1-methoxy-2-(3-methoxypropoxy)benzene; 3-[5-[(2R)-2-(chloromethyl)-3-methylbutyl]-2-methoxyphenoxy]propyl methyl ether 324763-39-5 C17H27ClO3 详情 详情
(XXXVI) 50580 (E)-3-[4-methoxy-3-(3-methoxypropoxy)phenyl]-2-propenoic acid C14H18O5 详情 详情
(XXXVII) 50581 3-[4-methoxy-3-(3-methoxypropoxy)phenyl]propionic acid C14H20O5 详情 详情
(XXXVIII) 50582 3-[4-methoxy-3-(3-methoxypropoxy)phenyl]propanoyl chloride C14H19ClO4 详情 详情
(XXXIX) 34409 (1S,2S)-2-(methylamino)-1-phenyl-1-propanol 90-82-4 C10H15NO 详情 详情
(XL) 50583 N-[(1S,2S)-2-hydroxy-1-methyl-2-phenylethyl]-3-[4-methoxy-3-(3-methoxypropoxy)phenyl]-N-methylpropanamide C24H33NO5 详情 详情
(XLI) 19369 2-iodopropane 75-30-9 C3H7I 详情 详情
(XLII) 50584 (2R)-N-[(1S,2S)-2-hydroxy-1-methyl-2-phenylethyl]-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-N,3-dimethylbutanamide C27H39NO5 详情 详情

合成路线6

The chiral azido intermediate (XXXIV) can also be obtained as follows: Reaction of (+)-pseudoephedrine isovaleramide (XLIII) with allyl bromide (XXI) by means of LDA in THF gives the pentenoyl amide (XLIV), which is treated with NBS in DME/water to yield the spiro compound (XLV). Hydrolysis of the bromomethyl group of (XLV) with tetrabutylammonium acetate and K2CO3 affords the carbinol (XLVI), which is oxidized to aldehyde (XLVII) with SO3/pyridine and TEA in DMSO/dichloromethane. Condensation of (XLVII) with the propyl chloride intermediate (XXX) by means of Mg, dibromoethane and CeCl3 in refluxing THF provides the already reported chiral hydroxylactone (XXXII), which is treated first with 4-bromobenzenesulfonyl chloride and then with NaN3 to give the desired azido derivative (XXXIV).

1 Mealy, N.E.; Castañer, R.M.; Silvestre, J.S.; Castañer, J.; Aliskiren Fumarate. Drugs Fut 2001, 26, 12, 1139.
2 Carey, J.S.; Sandham, D.A.; Taylor, R.J.; Fassler, A.; A convergent synthesis of the renin inhibitor CGP60536B. Tetrahedron Lett 2000, 41, 51, 10091.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XXI) 11463 3-Bromo-1-propene; 3-Bromopropene;allyl bromide 106-95-6 C3H5Br 详情 详情
(XXX) 50574 4-[(2R)-2-(chloromethyl)-3-methylbutyl]-1-methoxy-2-(3-methoxypropoxy)benzene; 3-[5-[(2R)-2-(chloromethyl)-3-methylbutyl]-2-methoxyphenoxy]propyl methyl ether 324763-39-5 C17H27ClO3 详情 详情
(XXXII) 50576 (3S,5S)-5-[(1R,3S)-1-hydroxy-3-[4-methoxy-3-(3-methoxypropoxy)benzyl]-4-methylpentyl]-3-isopropyldihydro-2(3H)-furanone C25H40O6 详情 详情
(XXXIV) 50578 (3S,5S)-5-[(1S,3S)-1-azido-3-[4-methoxy-3-(3-methoxypropoxy)benzyl]-4-methylpentyl]-3-isopropyldihydro-2(3H)-furanone C25H39N3O5 详情 详情
(XLIII) 50585 N-[(1S,2S)-2-hydroxy-1-methyl-2-phenylethyl]-N,3-dimethylbutanamide C15H23NO2 详情 详情
(XLIV) 50586 (2S)-N-[(1S,2S)-2-hydroxy-1-methyl-2-phenylethyl]-2-isopropyl-N-methyl-4-pentenamide C18H27NO2 详情 详情
(XLV) 50587 (2S,3S,5R,7S,9S)-7-(bromomethyl)-9-isopropyl-3,4-dimethyl-2-phenyl-1,6-dioxa-4-azaspiro[4.4]nonane C18H26BrNO2 详情 详情
(XLVI) 50588 [(2S,3S,5R,7S,9S)-9-isopropyl-3,4-dimethyl-2-phenyl-1,6-dioxa-4-azaspiro[4.4]non-7-yl]methanol C18H27NO3 详情 详情
(XLVII) 50589 (2S,3S,5R,7S,9S)-9-isopropyl-3,4-dimethyl-2-phenyl-1,6-dioxa-4-azaspiro[4.4]nonane-7-carbaldehyde C18H25NO3 详情 详情

合成路线7

Alternatively, the chiral azido intermediate (XXXIV) can also be synthesized as follows: Alkylation of oxazolidinone (V) with 1-chloro-3-iodopropene (XLVIII) by means of LiHMDS in THF gives compound (XLIX), which is condensed with the magnesium derivative of the phenylpropyl chloride (XXX) to yield, after working up, amide (L). Bromination of (L) with NBS and phosphoric acid affords the bromolactone (LI), which by treatment with NaN3 in tripropylene glycol/water provides the azido derivative (XXXIV).

1 Mealy, N.E.; Castañer, R.M.; Silvestre, J.S.; Castañer, J.; Aliskiren Fumarate. Drugs Fut 2001, 26, 12, 1139.
2 Stutz, S.; Herold, P. (Speedel Pharma Inc.); 2-Alkyl-5-halogen-pent-4-ene carboxylic acids and their production. WO 0109079; WO 0109083 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(V) 28131 (4S)-4-benzyl-3-(3-methylbutanoyl)-1,3-oxazolidin-2-one C15H19NO3 详情 详情
(XXX) 50574 4-[(2R)-2-(chloromethyl)-3-methylbutyl]-1-methoxy-2-(3-methoxypropoxy)benzene; 3-[5-[(2R)-2-(chloromethyl)-3-methylbutyl]-2-methoxyphenoxy]propyl methyl ether 324763-39-5 C17H27ClO3 详情 详情
(XXXIV) 50578 (3S,5S)-5-[(1S,3S)-1-azido-3-[4-methoxy-3-(3-methoxypropoxy)benzyl]-4-methylpentyl]-3-isopropyldihydro-2(3H)-furanone C25H39N3O5 详情 详情
(XLVIII) 50590 (E)-1-chloro-3-iodo-1-propene C3H4ClI 详情 详情
(XLIX) 50591 (4S)-4-benzyl-3-[(2S,4E)-5-chloro-2-isopropyl-4-pentenoyl]-1,3-oxazolidin-2-one C18H22ClNO3 详情 详情
(L) 50592 (4S)-4-benzyl-3-[(2S,4E,7R)-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methyl-4-nonenoyl]-1,3-oxazolidin-2-one C35H49NO6 详情 详情
(LI) 50593 (3S,5S)-5-[(1R,3S)-1-bromo-3-[4-methoxy-3-(3-methoxypropoxy)benzyl]-4-methylpentyl]-3-isopropyldihydro-2(3H)-furanone C25H39BrO5 详情 详情

合成路线8

Alternatively, the spiro aldehyde (XLVII) is treated with N-benzylhydroxylamine in dichloromethane to give nitrone (LII), which is submitted to a Grignard reaction with the magnesium derivative of intermediate (XXX) in THF to afford the adduct (LIII) as a mixture of epimers at the amino group. Simultaneous N-dehydroxylation and cleavage of the spiro function of (LIII) by means of Zn, Cu(OAc)2 in AcOH/water gives lactone (LIV), which is condensed with 3-amino-2,2-dimethylpropionamide (XIX) by means of TEA and 2-hydroxypyridine giving the adduct (LV). Finally, the benzylamino group of (LV) is removed with H2 over Pd/C in methanol to yield a mixture of two epimers at the amino group, from which aliskiren is separated.

1 De Lathauwer, G.; Perrone, D.; Dondoni, A.; A convergent synthesis of the renin inhibitor SPP-100 using a nitrone intermediate. Tetrahedron Lett 2001, 42, 29, 4819.
2 Mealy, N.E.; Castañer, R.M.; Silvestre, J.S.; Castañer, J.; Aliskiren Fumarate. Drugs Fut 2001, 26, 12, 1139.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XIX) 28129 3-amino-2,2-dimethylpropanamide 324763-51-1 C5H12N2O 详情 详情
(XXX) 50574 4-[(2R)-2-(chloromethyl)-3-methylbutyl]-1-methoxy-2-(3-methoxypropoxy)benzene; 3-[5-[(2R)-2-(chloromethyl)-3-methylbutyl]-2-methoxyphenoxy]propyl methyl ether 324763-39-5 C17H27ClO3 详情 详情
(XLVII) 50589 (2S,3S,5R,7S,9S)-9-isopropyl-3,4-dimethyl-2-phenyl-1,6-dioxa-4-azaspiro[4.4]nonane-7-carbaldehyde C18H25NO3 详情 详情
(LII) 50597 benzyl[(E)-[(2S,3S,5R,7S,9S)-9-isopropyl-3,4-dimethyl-2-phenyl-1,6-dioxa-4-azaspiro[4.4]non-7-yl]methylidene]ammoniumolate C25H32N2O3 详情 详情
(LIII) 50594 N-benzyl-N-[(3S)-1-[(2S,3S,5R,7S,9S)-9-isopropyl-3,4-dimethyl-2-phenyl-1,6-dioxa-4-azaspiro[4.4]non-7-yl]-3-[4-methoxy-3-(3-methoxypropoxy)benzyl]-4-methylpentyl]hydroxylamine; (2S,3S,5R,7S,9S)-7-[(3S)-1-[benzyl(hydroxy)amino]-3-[4-methoxy-3-(3-methoxypropoxy)benzyl]-4-methylpentyl]-9-isopropyl-3,4-dimethyl-2-phenyl-1,6-dioxa-4-azaspiro[4.4]nonane C42H60N2O6 详情 详情
(LIV) 50595 (3S,5S)-5-[(3S)-1-(benzylamino)-3-[4-methoxy-3-(3-methoxypropoxy)benzyl]-4-methylpentyl]-3-isopropyldihydro-2(3H)-furanone C32H47NO5 详情 详情
(LV) 50596 (2S,4S,7S)-N-(3-amino-2,2-dimethyl-3-oxopropyl)-5-(benzylamino)-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methylnonanamide C37H59N3O6 详情 详情

合成路线9

The condensation of ethyl isovalerate (I) with 1,3-dichloropropene (II) by means of BuLi and DIA in THF gives 5-chloro-2-isopropyl-4-pentenoic acid ethyl ester (III), which is hydrolyzed with NaOH in ethanol to yield the corresponding racemic acid (IV). The optical resolution of (IV) is carried out by means of cinchonidine and TEA in THF to afford 5-chloro-2(S)-isopropyl-4-pentenoic acid (V), which can also be obtained by asymmetric synthesis as follows: Condensation of 4(S)-benzyl-3-(3-methylbutyryl)oxazolidin-2-one (VI) with 3-iodo-1-propenyl chloride (VII) by means of LiHMDS in THF gives 4(S)-benzyl-3-(2(S)-isopropyl-3-methylbutyryl)oxazolidin-2-one (VIII), which is hydrolyzed with LiOH in THF/water to afford the chiral pentanoic acid (V). The reaction of (V) with oxalyl chloride in toluene gives the corresponding acyl chloride (IX), which is treated with dimethylamine and pyridine in dichloromethane to yield the dimethylamide (X). The condensation of (X) with the chiral chloro derivative (XI) (obtained by reaction of the corresponding alcohol (XII) with CCl4 and trioctylphosphine) by means of Mg and 1,2-dibromoethane in THF affords the octenamide (XIII). The cyclization of (XIII) by means of phosphoric acid and simultaneous bromination with NBS in THF provides the chiral bromolactone (XIV), which is opened by means of dimethylamine and Et2AlCl in dichloromethane to give the chiral 5-bromo-4-hydroxy-2,7-diisopropyloctanamide (XV). The reaction of (XV) with acetic anhydride and pyridine in dichloromethane yields the acetoxy derivative (XVI), which is treated with LiN3 to afford the 5(S)-azido derivative (XVII).

1 Herold, P.; Stutz, S. (Speedel Pharma Inc.); Process for the preparation of substd. octanoyl amides. WO 0208172 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 61601 ethyl isovalerate; Ethyl 3-methylbutanoate; Ethyl beta-methyl butyrate; Ethyl isovalerianate; ETHYL ISOVALERATE, NATURAL; Ethyl Isovalerate, Fcc; Isovaleriansaeure ethylester; Isovaleric Acid Ethyl Ester; iso-Valeric Acid Ethyl Ester; Ethyl isopentanoate; Ethyl isovalerate with G.C.; Ethyl Iso Valerate; Iso C-5 Ethyl Ester; Ethyl isopentanoate; 3-Methylbutyric acid ethyl ester 108-64-5 C7H14O2 详情 详情
(II) 61605 1,3-Dichloropropene; cis-1,3-Dichloropropylene; trans-1,3-Dichloropropene; 3-Chloroallyl Chloride; 3-Chloropropenyl Chloride; Telone; Telone II Soil Fumigant; 1,3-Dichloropropylene; alpha-Chloroallyl Chloride; Chloroallyl Chloride; 1,3-Dichloro-1-Propene; Telone II; cis-1,3-Dichloropropene; alpha,gamma-Dichloropropylene; gamma-chloroallyl chloride; cis-1,3-dichloro-1-propene; trans-1,3-dichloro-1-propene; 1,3-Dichloropropene (mixed isomers); (E)-1,3-dichloro-1-Propene; (Z)-1,3-dichloro-1-Propene; D-D92; (Z)-1,3-dichloropropene; 1,3-Dichloro-1-propene (Z); trans-1,3-dichloropropylene; E-1,3-Dichloropropene; 1,3-dichloro-1-propylene; 1,3-dichloropropene-1; dorlone ii; Tri-Form; 1,3-D; Telone IIR; Chloropropenyl chloride; 1,3-Dichloro-2-propene; 1,3-Dichloropropene, E,Z-; 1,3-Dichloropropene (mixed); 1,3-Dichloropropene (cis+trans); Cis-1,3-Dichloro-1-Propene, Te Ch; Trans-1,3-Dichloro-1-Propene,tech; 1,3-Dichloropropene, Mixture Of Isomers, 92%; 1,3-Dichloropropene, mixture of isomers; G 542-75-6 C3H4Cl2 详情 详情
(III) 61602 ethyl (E)-5-chloro-2-isopropyl-4-pentenoate C10H17ClO2 详情 详情
(IV) 61603 (E)-5-chloro-2-isopropyl-4-pentenoic acid C8H13ClO2 详情 详情
(V) 61604 (2S,4E)-5-chloro-2-isopropyl-4-pentenoic acid 324519-66-6 C8H13ClO2 详情 详情
(VI) 61606 (4S)-4-benzyl-3-(3-methylbutanoyl)-1,3-oxazolidin-2-one C15H19NO3 详情 详情
(VII) 50590 (E)-1-chloro-3-iodo-1-propene C3H4ClI 详情 详情
(VIII) 50591 (4S)-4-benzyl-3-[(2S,4E)-5-chloro-2-isopropyl-4-pentenoyl]-1,3-oxazolidin-2-one C18H22ClNO3 详情 详情
(IX) 61607 (2S,4E)-5-chloro-2-isopropyl-4-pentenoyl chloride C8H12Cl2O 详情 详情
(X) 61608 (2S,4E)-5-chloro-2-isopropyl-N,N-dimethyl-4-pentenamide 324519-68-8 C10H18ClNO 详情 详情
(XI) 50574 4-[(2R)-2-(chloromethyl)-3-methylbutyl]-1-methoxy-2-(3-methoxypropoxy)benzene; 3-[5-[(2R)-2-(chloromethyl)-3-methylbutyl]-2-methoxyphenoxy]propyl methyl ether 324763-39-5 C17H27ClO3 详情 详情
(XII) 50573 (2R)-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methyl-1-butanol C17H28O4 详情 详情
(XIII) 61609 (2S,4E,7R)-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-N,N,8-trimethyl-4-nonenamide C27H45NO4 详情 详情
(XIV) 50593 (3S,5S)-5-[(1R,3S)-1-bromo-3-[4-methoxy-3-(3-methoxypropoxy)benzyl]-4-methylpentyl]-3-isopropyldihydro-2(3H)-furanone C25H39BrO5 详情 详情
(XV) 61610 (2S,4S,5R,7S)-5-bromo-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-N,N,8-trimethylnonanamide C27H46BrNO5 详情 详情
(XVI) 61611 (1S,2R,4S)-2-bromo-1-{(2S)-2-[(dimethylamino)carbonyl]-3-methylbutyl}-4-[4-methoxy-3-(3-methoxypropoxy)benzyl]-5-methylhexyl acetate C29H48BrNO6 详情 详情
(XVII) 61612 (1S,2S,4S)-2-azido-1-{(2S)-2-[(dimethylamino)carbonyl]-3-methylbutyl}-4-[4-methoxy-3-(3-methoxypropoxy)benzyl]-5-methylhexyl acetate C29H48N4O6 详情 详情

合成路线10

The cyclization of (XVII) by means of TsOH in refluxing methanol gives the chiral lactone (XVIII), which is condensed with 3-amino-2,2-dimethylpropionamide (XIX) by means of TEA and 2-hydroxypyridine at 90 C to yield the corresponding amide (XX). Finally, the azido group of (XX) is reduced with H2 over Pd/C in tert-butyl methyl ether to afford the target Aliskiren.

1 Herold, P.; Stutz, S. (Speedel Pharma Inc.); Process for the preparation of substd. octanoyl amides. WO 0208172 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XVII) 61612 (1S,2S,4S)-2-azido-1-{(2S)-2-[(dimethylamino)carbonyl]-3-methylbutyl}-4-[4-methoxy-3-(3-methoxypropoxy)benzyl]-5-methylhexyl acetate C29H48N4O6 详情 详情
(XVIII) 50578 (3S,5S)-5-[(1S,3S)-1-azido-3-[4-methoxy-3-(3-methoxypropoxy)benzyl]-4-methylpentyl]-3-isopropyldihydro-2(3H)-furanone C25H39N3O5 详情 详情
(XIX) 28129 3-amino-2,2-dimethylpropanamide 324763-51-1 C5H12N2O 详情 详情
(XX) 61613 (2S,4S,5S,7S)-N-(3-amino-2,2-dimethyl-3-oxopropyl)-5-azido-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methylnonanamide C30H51N5O6 详情 详情

合成路线11

The condensation of the chiral chloro derivative (I) with 5-chloro-[2(S)-isopropyl]-4-pentanoic acid methyl ester (II) by means of Mg and dibromoethane in THF gives the chiral octenoic ester (III) which is converted to the corresponding acid (IV) by means of LiOH in THF/methanol/water. The reaction of (IV) with NBS in dichloromethane yields the bromolactone (V), which is treated with LiOH in isopropanol to yield the epoxide (VI). This compound, without isolation, is treated with HCl in the same solvent to afford the chiral hydroxylactone (VII). The reaction of the OH group of (VII) with MsCl and pyridine in toluene provides the mesylate (VIII), which is treated with NaN3 in hot 1,3-dimethylperhydropyrimidin-2-one to give the azido derivative (IX). The condensation of (IX) with 3-amino-2,2-dimethylpropionamide (X) by means of 2-hydroxypyridine in hot TEA yields the carboxamide (XI). Finally, the azido group of (XI) is reduced with H2 over Pd/C in tert-butyl methyl ether to provide the target Aliskiren.

1 Herold, P.; Stutz, S.; Spindler, F. (Speedel Pharma Inc.); Process for the preparation of substd. octanoyl amides. WO 0202508 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 50574 4-[(2R)-2-(chloromethyl)-3-methylbutyl]-1-methoxy-2-(3-methoxypropoxy)benzene; 3-[5-[(2R)-2-(chloromethyl)-3-methylbutyl]-2-methoxyphenoxy]propyl methyl ether 324763-39-5 C17H27ClO3 详情 详情
(II) 61614 methyl (2S,4E)-5-chloro-2-isopropyl-4-pentenoate C9H15ClO2 详情 详情
(III) 61615 methyl (2S,4E,7R)-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methyl-4-nonenoate C26H42O5 详情 详情
(IV) 61616 (2S,4E,7R)-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methyl-4-nonenoic acid C25H40O5 详情 详情
(V) 61617 (3S,5R)-5-{(1S,3S)-1-bromo-3-[4-methoxy-3-(3-methoxypropoxy)benzyl]-4-methylpentyl}-3-isopropyldihydro-2(3H)-furanone C25H39BrO5 详情 详情
(VI) 61618 lithium (2S)-2-[((2R,3R)-3-{(2S)-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methylbutyl}oxiranyl)methyl]-3-methylbutanoate C25H39LiO6 详情 详情
(VII) 50576 (3S,5S)-5-[(1R,3S)-1-hydroxy-3-[4-methoxy-3-(3-methoxypropoxy)benzyl]-4-methylpentyl]-3-isopropyldihydro-2(3H)-furanone C25H40O6 详情 详情
(VIII) 61619 (1R,3S)-1-[(2S,4S)-4-isopropyl-5-oxotetrahydro-2-furanyl]-3-[4-methoxy-3-(3-methoxypropoxy)benzyl]-4-methylpentyl methanesulfonate C26H42O8S 详情 详情
(IX) 50578 (3S,5S)-5-[(1S,3S)-1-azido-3-[4-methoxy-3-(3-methoxypropoxy)benzyl]-4-methylpentyl]-3-isopropyldihydro-2(3H)-furanone C25H39N3O5 详情 详情
(X) 28129 3-amino-2,2-dimethylpropanamide 324763-51-1 C5H12N2O 详情 详情
(XI) 61613 (2S,4S,5S,7S)-N-(3-amino-2,2-dimethyl-3-oxopropyl)-5-azido-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methylnonanamide C30H51N5O6 详情 详情

合成路线12

The condensation of benzaldehyde (I) with ethyl isovalerate (II) by means of hexyl lithium and DIA in THF gives the hydroxyester (III), which is acylated with Ac2O and DMAP in THF to yield the acetoxy derivative (IV). The elimination reaction in (IV) by means of t-BuOK in THF affords the unsaturated ester (V), which is reduced with diisobutylaluminum hydride in toluene to provide the unsaturated alcohol (VI). Finally, this compound is enantioselectively reduced with H2 over a chiral biphenylyl diphenylphosphine catalyst and a [Rh(norbornadiene)Cl]2 catalyst in toluene to give the target intermediate 2(R)-isopropyl-3-[4-methoxy-3-(3-methoxypropoxy)phenyl]-1-propanol (VII). (see scheme 26758001d, intermediate (XXIX)).

1 Herold, P.; Stutz, S.; Spindler, F. (Speedel Pharma Inc.); Process for the preparation of (R)-2-alkyl-3-phenyl-1-propanols. WO 0202487 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 61620 4-Methoxy-3-(3-methoxypropoxy)benzaldehyde 172900-75-3 C12H16O4 详情 详情
(II) 61621 propyl 3-methylbutanoate C8H16O2 详情 详情
(III) 61622 propyl 2-{hydroxy[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl}-3-methylbutanoate C20H32O6 详情 详情
(IV) 61623 propyl 2-{(acetyloxy)[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl}-3-methylbutanoate C22H34O7 详情 详情
(V) 61624 propyl (E)-2-isopropyl-3-[4-methoxy-3-(3-methoxypropoxy)phenyl]-2-propenoate C20H30O5 详情 详情
(VI) 61625 (E)-2-isopropyl-3-[4-methoxy-3-(3-methoxypropoxy)phenyl]-2-propen-1-ol C17H26O4 详情 详情
(VII) 50573 (2R)-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methyl-1-butanol C17H28O4 详情 详情

合成路线13

The condensation of benzaldehyde (I) with ethyl isovalerate (II) by means of hexyl lithium and DIA in THF gives the hydroxyester (III), which is acylated with Ac2O and DMAP in THF to yield the acetoxy derivate (IV). The elimination reaction in (IV) by means of t-BuOK in THF affords the unsaturated ester (V), which is hydrolyzed with KOH in ethanol to provide the unsaturated free acid (VI). Finally, this compound is enantioselectively reduced with H2 over several chiral Rh catalysts {[Rh(NBD)2BF4, [Rh(NBD)(OCOCF3)2], [Rh(NBD)Cl2], etc} to give the target intermediate 2(R)-isopropyl-3-[4-methoxy-3-(3-methoxypropoxy)phenyl]propionic acid (VII). (see scheme 26758001a, intermediate (VII)).

1 Herold, P.; Stutz, S. (Speedel Pharma Inc.); Preparation of (R)-2-alkyl-3-phenylpropionic acids. WO 0202500 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 61620 4-Methoxy-3-(3-methoxypropoxy)benzaldehyde 172900-75-3 C12H16O4 详情 详情
(II) 61621 propyl 3-methylbutanoate C8H16O2 详情 详情
(III) 61622 propyl 2-{hydroxy[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl}-3-methylbutanoate C20H32O6 详情 详情
(IV) 61623 propyl 2-{(acetyloxy)[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl}-3-methylbutanoate C22H34O7 详情 详情
(V) 61624 propyl (E)-2-isopropyl-3-[4-methoxy-3-(3-methoxypropoxy)phenyl]-2-propenoate C20H30O5 详情 详情
(VI) 61626 (E)-2-isopropyl-3-[4-methoxy-3-(3-methoxypropoxy)phenyl]-2-propenoic acid C17H24O5 详情 详情
(VII) 28119 (2R)-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methylbutyric acid C17H26O5 详情 详情

合成路线14

 

1 Maibaum J, Stutz S, Goschke R, et al. 2007. Structural modification of the P2' position of 2,7-dialkyl-substituted 5(S)-amino-4(S)-hydro-8-phenyl-octanecarboxamides: the discovery of aliskiren, a potent nonpeptide human renin inhibitor active after once daily dosing in marmosets. J Med Chem, 50(20): 4832~4844
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(II) 66991 (R)-((2-(bromomethyl)-3-methylbutoxy)methyl)benzene   C13H19BrO 详情 详情
(V) 66992     C40H63NO7 详情 详情
(VIII) 28129 3-amino-2,2-dimethylpropanamide 324763-51-1 C5H12N2O 详情 详情
(I) 28123 tert-butyl (1S,3S)-1-formyl-3-[4-methoxy-3-(3-methoxypropoxy)benzyl]-4-methylpentylcarbamate C24H39NO6 详情 详情
(III) 28125 tert-butyl (1S,4S)-4-[(benzyloxy)methyl]-2-hydroxy-1-[(2S)-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methylbutyl]-5-methylhexylcarbamate C37H59NO7 详情 详情
(IV) 10722 1-Methoxy-1-methylethyl methyl ether; 2,2-Dimethoxypropane 77-76-9 C5H12O2 详情 详情
(VI) 28127 tert-butyl (4S,5S)-5-[(2S)-2-(hydroxymethyl)-3-methylbutyl]-4-[(2S)-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methylbutyl]-2,2-dimethyl-1,3-oxazolidine-3-carboxylate C33H57NO7 详情 详情
(VII) 28128 (2S)-2-[((4S,5S)-3-(tert-butoxycarbonyl)-4-[(2S)-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methylbutyl]-2,2-dimethyl-1,3-oxazolidin-5-yl)methyl]-3-methylbutyric acid C33H55NO8 详情 详情
(IX) 28130 tert-butyl (4S,5S)-5-((2S)-2-[[(3-amino-2,2-dimethyl-3-oxopropyl)amino]carbonyl]-3-methylbutyl)-4-[(2S)-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methylbutyl]-2,2-dimethyl-1,3-oxazolidine-3-carboxylate C38H65N3O8 详情 详情
(X) 66994 tert-butyl (8-((3-amino-2,2-dimethyl-3-oxopropyl)carbamoyl)-6-hydroxy-3-(4-methoxy-3-(3-methoxypropoxy)benzyl)-2,9-dimethyldecan-5-yl)carbamate   C35H61N3O8 详情 详情
(XII) 28126 tert-butyl (4S,5S)-5-[(2S)-2-[(benzyloxy)methyl]-3-methylbutyl]-4-[(2S)-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methylbutyl]-2,2-dimethyl-1,3-oxazolidine-3-carboxylate C40H63NO7 详情 详情

合成路线15

 

1 Lindsay KB. Skrydstrup T. 2006. Formal total synthesisi of the potent renin inhibitory aliskiren: Application of a Sml-promoted acyl-like radical coupling. J Org Chem, 71(13): 4766~4777
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XI) 67001 benzyl (1-(4-(2-hydroxypropan-2-yl)-5-oxotetrahydrofuran-2-yl)-3-(4-methoxy-3-(3-methoxypropoxy)benzyl)-4-methylpentyl)carbamate   C33H47NO8 详情 详情
(I) 28120 3-[5-[(2R)-2-(bromomethyl)-3-methylbutyl]-2-methoxyphenoxy]propyl methyl ether 172900-69-5 C17H27BrO3 详情 详情
(II) 10296 (R)-2,5-Dihydro-3,6-dimethoxy-2-isopropylpyrazine; (3R)-3-Isopropyl-5-methoxy-3,6-dihydro-2-pyrazinyl methyl ether; (2R)-2-Isopropyl-3,6-dimethoxy-2,5-dihydropyrazine 109838-85-9 C9H16N2O2 详情 详情
(III) 28121 (2R,5S)-2-isopropyl-3,6-dimethoxy-5-[(2S)-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methylbutyl]-2,5-dihydropyrazine C26H42N2O5 详情 详情
(IV) 66995 (2R,4R)-methyl 2-amino-4-(4-methoxy-3-(3-methoxypropoxy)benzyl)-5-methylhexanoate   C20H33NO5 详情 详情
(V) 66996 methyl 2-(((benzyloxy)carbonyl)amino)-4-(4-methoxy-3-(3-methoxypropoxy)benzyl)-5-methylhexanoate   C28H39NO7 详情 详情
(VI) 66997 2-(((benzyloxy)carbonyl)amino)-4-(4-methoxy-3-(3-methoxypropoxy)benzyl)-5-methylhexanoic acid   C27H37NO7 详情 详情
(VII) 27936 4-Mercaptopyridine; 4-pyridinethiol 4556-23-4 C5H5NS 详情 详情
(VIII) 66998     C32H40N2O6S 详情 详情
(IX) 66999 methyl 5-(((benzyloxy)carbonyl)amino)-7-(4-methoxy-3-(3-methoxypropoxy)benzyl)-8-methyl-4-oxononanoate   C31H43NO8 详情 详情
(X) 67000 benzyl (3-(4-methoxy-3-(3-methoxypropoxy)benzyl)-4-methyl-1-(5-oxotetrahydrofuran-2-yl)pentyl)carbamate   C30H41NO7 详情 详情
(XII) 67002 benzyl (3-(4-methoxy-3-(3-methoxypropoxy)benzyl)-4-methyl-1-(5-oxo-4-(prop-1-en-2-yl)tetrahydrofuran-2-yl)pentyl)carbamate   C33H45NO7 详情 详情
(XIII) 67003 5-(1-amino-3-(4-methoxy-3-(3-methoxypropoxy)benzyl)-4-methylpentyl)-3-isopropyldihydrofuran-2(3H)-one   C25H41NO5 详情 详情
(XIV) 67004 tert-butyl (1-(4-isopropyl-5-oxotetrahydrofuran-2-yl)-3-(4-methoxy-3-(3-methoxypropoxy)benzyl)-4-methylpentyl)carbamate   C30H49NO7 详情 详情
(XV) 28129 3-amino-2,2-dimethylpropanamide 324763-51-1 C5H12N2O 详情 详情
(XVI) 67005 tert-butyl (8-((3-amino-2,2-dimethyl-3-oxopropyl)carbamoyl)-6-hydroxy-3-(4-methoxy-3-(3-methoxypropoxy)benzyl)-2,9-dimethyldecan-5-yl)carbamate   C35H61N3O8 详情 详情

合成路线16

 

1 Dondoni A, De Lathauwer G. 2001. A convergent synthesisi of the renin inhibitor SPP-100 using a nitrone intermediate. Tetrahedron Lett. 42(29): 4819~4823
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(R-5) 50594 N-benzyl-N-[(3S)-1-[(2S,3S,5R,7S,9S)-9-isopropyl-3,4-dimethyl-2-phenyl-1,6-dioxa-4-azaspiro[4.4]non-7-yl]-3-[4-methoxy-3-(3-methoxypropoxy)benzyl]-4-methylpentyl]hydroxylamine; (2S,3S,5R,7S,9S)-7-[(3S)-1-[benzyl(hydroxy)amino]-3-[4-methoxy-3-(3-methoxypropoxy)benzyl]-4-methylpentyl]-9-isopropyl-3,4-dimethyl-2-phenyl-1,6-dioxa-4-azaspiro[4.4]nonane C42H60N2O6 详情 详情
(I) 50588 [(2S,3S,5R,7S,9S)-9-isopropyl-3,4-dimethyl-2-phenyl-1,6-dioxa-4-azaspiro[4.4]non-7-yl]methanol C18H27NO3 详情 详情
(II) 50589 (2S,3S,5R,7S,9S)-9-isopropyl-3,4-dimethyl-2-phenyl-1,6-dioxa-4-azaspiro[4.4]nonane-7-carbaldehyde C18H25NO3 详情 详情
(III) 50597 benzyl[(E)-[(2S,3S,5R,7S,9S)-9-isopropyl-3,4-dimethyl-2-phenyl-1,6-dioxa-4-azaspiro[4.4]non-7-yl]methylidene]ammoniumolate C25H32N2O3 详情 详情
(IV) 50574 4-[(2R)-2-(chloromethyl)-3-methylbutyl]-1-methoxy-2-(3-methoxypropoxy)benzene; 3-[5-[(2R)-2-(chloromethyl)-3-methylbutyl]-2-methoxyphenoxy]propyl methyl ether 324763-39-5 C17H27ClO3 详情 详情
(VI) 67006 5-(1-(benzyl(hydroxy)amino)-3-(4-methoxy-3-(3-methoxypropoxy)benzyl)-4-methylpentyl)-3-isopropyldihydrofuran-2(3H)-one   C32H47NO6 详情 详情
(VII) 28129 3-amino-2,2-dimethylpropanamide 324763-51-1 C5H12N2O 详情 详情
(VIII) 67007 N-(3-amino-2,2-dimethyl-3-oxopropyl)-5-(benzylamino)-4-hydroxy-2-isopropyl-7-(4-methoxy-3-(3-methoxypropoxy)benzyl)-8-methylnonanamide   C37H59N3O6 详情 详情

合成路线17

  

1 Sandham DA, Taylor RJ, Carey JS, et al. 2000. A convergent synthesis of the renin inhibitory CGP60536B. Tetrahedron Lett, 41(51): 10091~10094
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VI) 50585 N-[(1S,2S)-2-hydroxy-1-methyl-2-phenylethyl]-N,3-dimethylbutanamide C15H23NO2 详情 详情
(I) 50580 (E)-3-[4-methoxy-3-(3-methoxypropoxy)phenyl]-2-propenoic acid C14H18O5 详情 详情
(II) 50583 N-[(1S,2S)-2-hydroxy-1-methyl-2-phenylethyl]-3-[4-methoxy-3-(3-methoxypropoxy)phenyl]-N-methylpropanamide C24H33NO5 详情 详情
(III) 50584 (2R)-N-[(1S,2S)-2-hydroxy-1-methyl-2-phenylethyl]-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-N,3-dimethylbutanamide C27H39NO5 详情 详情
(IV) 50573 (2R)-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methyl-1-butanol C17H28O4 详情 详情
(V) 50574 4-[(2R)-2-(chloromethyl)-3-methylbutyl]-1-methoxy-2-(3-methoxypropoxy)benzene; 3-[5-[(2R)-2-(chloromethyl)-3-methylbutyl]-2-methoxyphenoxy]propyl methyl ether 324763-39-5 C17H27ClO3 详情 详情
(VII) 50586 (2S)-N-[(1S,2S)-2-hydroxy-1-methyl-2-phenylethyl]-2-isopropyl-N-methyl-4-pentenamide C18H27NO2 详情 详情
(VIII) 50587 (2S,3S,5R,7S,9S)-7-(bromomethyl)-9-isopropyl-3,4-dimethyl-2-phenyl-1,6-dioxa-4-azaspiro[4.4]nonane C18H26BrNO2 详情 详情
(IX) 50588 [(2S,3S,5R,7S,9S)-9-isopropyl-3,4-dimethyl-2-phenyl-1,6-dioxa-4-azaspiro[4.4]non-7-yl]methanol C18H27NO3 详情 详情
(X) 50589 (2S,3S,5R,7S,9S)-9-isopropyl-3,4-dimethyl-2-phenyl-1,6-dioxa-4-azaspiro[4.4]nonane-7-carbaldehyde C18H25NO3 详情 详情
(XI) 50576 (3S,5S)-5-[(1R,3S)-1-hydroxy-3-[4-methoxy-3-(3-methoxypropoxy)benzyl]-4-methylpentyl]-3-isopropyldihydro-2(3H)-furanone C25H40O6 详情 详情
(XII) 50578 (3S,5S)-5-[(1S,3S)-1-azido-3-[4-methoxy-3-(3-methoxypropoxy)benzyl]-4-methylpentyl]-3-isopropyldihydro-2(3H)-furanone C25H39N3O5 详情 详情
(XIII) 28129 3-amino-2,2-dimethylpropanamide 324763-51-1 C5H12N2O 详情 详情
(XIV) 61613 (2S,4S,5S,7S)-N-(3-amino-2,2-dimethyl-3-oxopropyl)-5-azido-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methylnonanamide C30H51N5O6 详情 详情

合成路线18

 

1 Rueger H, Stutz S, Goschke R, et al. 2000. A convergent synthesisi approach towards CGP60536B, a nonpeptide orally potent renin inhibitory, via an enantiomerically pure keto lactone intermediate. Tetrahedron Lett, 41(51): 10085~10089
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 28131 (4S)-4-benzyl-3-(3-methylbutanoyl)-1,3-oxazolidin-2-one C15H19NO3 详情 详情
(II) 50566 (4S)-4-benzyl-3-[(2S)-2-isopropyl-4-pentenoyl]-1,3-oxazolidin-2-one C18H23NO3 详情 详情
(III) 50567 (3S)-5-(hydroxymethyl)-3-isopropyldihydro-2(3H)-furanone C8H14O3 详情 详情
(IV) 50569 (4S)-4-isopropyl-5-oxotetrahydro-2-furancarbonyl chloride C8H11ClO3 详情 详情
(V) 67008 benzyl (2S,4R)-4-isopropyl-5-oxotetrahydro-2-furancarboxylate   C15H18O4 详情 详情
(VI) 50570 benzyl (2S,4S)-4-isopropyl-5-oxotetrahydro-2-furancarboxylate C15H18O4 详情 详情
(VII) 50571 (2S,4S)-4-isopropyl-5-oxotetrahydro-2-furancarboxylic acid C8H12O4 详情 详情
(VIII) 50572 (2S,4S)-4-isopropyl-5-oxotetrahydro-2-furancarbonyl chloride C8H11ClO3 详情 详情
(IX) 28119 (2R)-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methylbutyric acid C17H26O5 详情 详情
(X) 50573 (2R)-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methyl-1-butanol C17H28O4 详情 详情
(XI) 50574 4-[(2R)-2-(chloromethyl)-3-methylbutyl]-1-methoxy-2-(3-methoxypropoxy)benzene; 3-[5-[(2R)-2-(chloromethyl)-3-methylbutyl]-2-methoxyphenoxy]propyl methyl ether 324763-39-5 C17H27ClO3 详情 详情
(XII) 50575 (3S,5S)-3-isopropyl-5-[(3S)-3-[4-methoxy-3-(3-methoxypropoxy)benzyl]-4-methylpentanoyl]dihydro-2(3H)-furanone C25H38O6 详情 详情
(XIII) 50576 (3S,5S)-5-[(1R,3S)-1-hydroxy-3-[4-methoxy-3-(3-methoxypropoxy)benzyl]-4-methylpentyl]-3-isopropyldihydro-2(3H)-furanone C25H40O6 详情 详情
(XIV) 50578 (3S,5S)-5-[(1S,3S)-1-azido-3-[4-methoxy-3-(3-methoxypropoxy)benzyl]-4-methylpentyl]-3-isopropyldihydro-2(3H)-furanone C25H39N3O5 详情 详情
(XV) 28129 3-amino-2,2-dimethylpropanamide 324763-51-1 C5H12N2O 详情 详情
(XVI) 50579 (2S,4S,5S,7S)-N-(4-amino-2,2-dimethyl-4-oxobutyl)-5-azido-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methylnonanamide C31H53N5O6 详情 详情

合成路线19

 

1 Dorg H, Zhang ZL, Huang JH, et al. 2005. Practical synthesisi of an orally active renin inhibitory aliskiren. Tetrahedron Lett, 46(37): 6337~6340
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XXV) 67017 2-cyano-2-methylpropanamide 7505-93-3 C5H8N2O 详情 详情
(I) 18455 3-hydroxy-4-methoxybenzaldehyde; Isovanillin 621-59-0 C8H8O3 详情 详情
(II) 67010 3-methoxypropyl methanesulfonate   C5H12O4S 详情 详情
(III) 61620 4-Methoxy-3-(3-methoxypropoxy)benzaldehyde 172900-75-3 C12H16O4 详情 详情
(IV) 28116 [4-methoxy-3-(3-methoxypropoxy)phenyl]methanol 172900-74-2 C12H18O4 详情 详情
(V) 28117 3-[5-(bromomethyl)-2-methoxyphenoxy]propyl methyl ether 172900-73-1 C12H17BrO3 详情 详情
(VI) 28131 (4S)-4-benzyl-3-(3-methylbutanoyl)-1,3-oxazolidin-2-one C15H19NO3 详情 详情
(VII) 28118 (4S)-4-benzyl-3-[(2R)-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methylbutanoyl]-1,3-oxazolidin-2-one C27H35NO6 详情 详情
(VIII) 28119 (2R)-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methylbutyric acid C17H26O5 详情 详情
(IX) 50573 (2R)-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methyl-1-butanol C17H28O4 详情 详情
(X) 28120 3-[5-[(2R)-2-(bromomethyl)-3-methylbutyl]-2-methoxyphenoxy]propyl methyl ether 172900-69-5 C17H27BrO3 详情 详情
(XI) 67009 (S)-3,6-diethoxy-2-isopropyl-2,5-dihydropyrazine 134870-62-5 C11H20N2O2 详情 详情
(XII) 67011 3,6-diethoxy-2-isopropyl-5-(2-(4-methoxy-3-(3-methoxypropoxy)benzyl)-3-methylbutyl)-2,5-dihydropyrazine   C28H46N2O5 详情 详情
(XIII) 67012 ethyl 2-amino-4-(4-methoxy-3-(3-methoxypropoxy)benzyl)-5-methylhexanoate   C21H35NO5 详情 详情
(XIV) 28122 methyl (2S,4S)-2-[(tert-butoxycarbonyl)amino]-4-[4-methoxy-3-(3-methoxypropoxy)benzyl]-5-methylhexanoate C25H41NO7 详情 详情
(XV) 67013 tert-butyl (1-hydroxy-4-(4-methoxy-3-(3-methoxypropoxy)benzyl)-5-methylhexan-2-yl)carbamate   C24H41NO6 详情 详情
(XVI) 28123 tert-butyl (1S,3S)-1-formyl-3-[4-methoxy-3-(3-methoxypropoxy)benzyl]-4-methylpentylcarbamate C24H39NO6 详情 详情
(XVII) 18710 Benzyl alcohol; Phenylmethanol 100-51-6 C7H8O 详情 详情
(XVIII) 14560 Benzyl chloromethyl ether; 1-[(chloromethoxy)methyl]benzene 3587-60-8 C8H9ClO 详情 详情
(XIX) 23285 (4R)-4-benzyl-3-(3-methylbutanoyl)-1,3-oxazolidin-2-one C15H19NO3 详情 详情
(XX) 67014 4-benzyl-3-(2-((benzyloxy)methyl)-3-methylbutanoyl)oxazolidin-2-one   C23H27NO4 详情 详情
(XXI) 67015 (R)-2-((benzyloxy)methyl)-3-methylbutanoic acid   C13H18O3 详情 详情
(XXII) 67016 2-((benzyloxy)methyl)-3-methylbutan-1-ol   C13H20O2 详情 详情
(XXIII) 66991 (R)-((2-(bromomethyl)-3-methylbutoxy)methyl)benzene   C13H19BrO 详情 详情
(XXIV) 12122 Cyanoacetamide; 2-Cyanoacetamide 107-91-5 C3H4N2O 详情 详情
(XXVI) 67018 benzyl (3-amino-2,2-dimethyl-3-oxopropyl)carbamate   C13H18N2O3 详情 详情
(XXVII) 28129 3-amino-2,2-dimethylpropanamide 324763-51-1 C5H12N2O 详情 详情
(XXVIII) 28125 tert-butyl (1S,4S)-4-[(benzyloxy)methyl]-2-hydroxy-1-[(2S)-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methylbutyl]-5-methylhexylcarbamate C37H59NO7 详情 详情
(XXIX) 67019 tert-butyl (6-hydroxy-8-(hydroxymethyl)-3-(4-methoxy-3-(3-methoxypropoxy)benzyl)-2,9-dimethyldecan-5-yl)carbamate   C30H53NO7 详情 详情
(XXX) 67004 tert-butyl (1-(4-isopropyl-5-oxotetrahydrofuran-2-yl)-3-(4-methoxy-3-(3-methoxypropoxy)benzyl)-4-methylpentyl)carbamate   C30H49NO7 详情 详情
(XXXI) 67020 tert-butyl (8-((1-amino-2-methyl-1-oxopropan-2-yl)carbamoyl)-6-hydroxy-3-(4-methoxy-3-(3-methoxypropoxy)benzyl)-2,9-dimethyldecan-5-yl)carbamate   C34H59N3O8 详情 详情
Extended Information